The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial results: https://nej.md/3MBP1uc | The New England Journal of Medicine
1:56
The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial results: https://nej.md/3MBP1uc | The New England Journal of Medicine
4.4K viewsMar 15, 2025
FacebookThe New England Journal of Medicine
See more
Static thumbnail place holder